BioAtla, Inc. (BCAB)
NASDAQ: BCAB · IEX Real-Time Price · USD
1.475
+0.060 (4.24%)
Jun 21, 2024, 12:12 PM EDT - Market open

BioAtla Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018
Net Income
-123.46-106.48-95.4-35.85-29.79
Upgrade
Depreciation & Amortization
1.221.21.331.010.86
Upgrade
Share-Based Compensation
13.5414.5625.123.020
Upgrade
Other Operating Activities
4.680.36.74-4.5119.29
Upgrade
Operating Cash Flow
-104.02-90.42-62.21-36.33-9.65
Upgrade
Capital Expenditures
-0.1-0.27-0.92-0.59-1.51
Upgrade
Investing Cash Flow
-0.1-0.27-0.92-0.59-1.51
Upgrade
Share Issuance / Repurchase
0.3461.9769.51200.230
Upgrade
Debt Issued / Paid
0003.434
Upgrade
Other Financing Activities
-0.26-0.76-68.16-0.01
Upgrade
Financing Cash Flow
0.0861.2169.51271.834
Upgrade
Net Cash Flow
-104.04-29.476.37234.9-7.16
Upgrade
Free Cash Flow
-104.11-90.69-63.14-36.92-11.15
Upgrade
Free Cash Flow Margin
---25255.20%-8606.99%-214.50%
Upgrade
Free Cash Flow Per Share
-2.18-2.33-1.83-4.38-0.20
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).